1.Inhibition of Hypoxic Pulmonary Vasoconstriction of Rats by Carbon Monoxide.
Hae Young YOO ; Su Jung PARK ; Jae Hyon BAHK ; Sung Joon KIM
Journal of Korean Medical Science 2010;25(10):1411-1417
Hypoxic pulmonary vasoconstriction (HPV), a unique response of pulmonary circulation, is critical to prevent hypoxemia under local hypoventilation. Hypoxic inhibition of K+ channel is known as an important O2-sensing mechanism in HPV. Carbon monoxide (CO) is suggested as a positive regulator of Ca2+-activated K+ channel (BK(Ca)), a stimulator of guanylate cyclase, and an O2-mimetic agent in heme moiety-dependent O2 sensing mechanisms. Here we compared the effects of CO on the HPV (Po2, 3%) in isolated pulmonary artery (HPV(PA)) and in blood-perfused/ventilated lungs (HPV(lung)) of rats. A pretreatment with CO (3%) abolished the HPV(PA) in a reversible manner. The inhibition of HPV(PA) was completely reversed by 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one (ODQ), a guanylate cyclase inhibitor. In contrast, the HPV(lung) was only partly decreased by CO. Moreover, the partial inhibition of HPV(lung) by CO was affected neither by the pretreatment with ODQ nor by NO synthase inhibitor (L-NAME). The CO-induced inhibitions of HPV(PA) and HPV(lung) were commonly unaffected by tetraethylammonium (TEA, 2 mM), a blocker of BK(Ca). As a whole, CO inhibits HPV(PA) via activating guanylate cyclase. The inconsistent effects of ODQ on HPV(PA) and HPV(lung) suggest that ODQ may lose its sGC inhibitory action when applied to the blood-containing perfusate.
Animals
;
Anoxia/*physiopathology
;
Carbon Monoxide/*pharmacology
;
Guanylate Cyclase/antagonists & inhibitors/metabolism
;
NG-Nitroarginine Methyl Ester/chemistry/pharmacology
;
Nitric Oxide Synthase/antagonists & inhibitors/metabolism
;
Oxadiazoles/chemistry/pharmacology
;
Pulmonary Artery/*physiopathology
;
Quinoxalines/chemistry/pharmacology
;
Rats
;
Tetraethylammonium/chemistry/pharmacology
;
Vasoconstriction/*drug effects/physiology
2.Resveratrol Inhibits Hypoxia-Induced Vascular Endothelial Growth Factor Expression and Pathological Neovascularization.
Christopher Seungkyu LEE ; Eun Young CHOI ; Sung Chul LEE ; Hyoung Jun KOH ; Joon Haeng LEE ; Ji Hyung CHUNG
Yonsei Medical Journal 2015;56(6):1678-1685
PURPOSE: To investigate the effects of resveratrol on the expression of hypoxia-inducible factor 1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) in human adult retinal pigment epithelial (ARPE-19) cells, and on experimental choroidal neovascularization (CNV) in mice. MATERIALS AND METHODS: ARPE-19 cells were treated with different concentrations of resveratrol and then incubated under hypoxic conditions with subsequent evaluation of cell viability, expression of HIF-1alpha, and expression of VEGF. The effects of resveratrol on the synthesis and degradation of hypoxia-induced HIF-1alpha were evaluated using inhibitors of the PI3K/Akt/mTOR and the ubiquitin proteasome pathways. In animal studies, CNV lesions were induced in C57BL/6 mice by laser photocoagulation. After 7 days of oral administration of resveratrol or vehicle, which began one day after CNV induction, image analysis was used to measure CNV areas on choroidal flat mounts stained with isolectin IB4. RESULTS: In ARPE-19 cells, resveratrol significantly inhibited HIF-1alpha and VEGF in a dose-dependent manner, by blocking the PI3K/Akt/mTOR signaling pathway and by promoting proteasomal HIF-1alpha degradation. In mice experiments, orally administered resveratrol significantly inhibited CNV growth in a dose-dependent manner. CONCLUSION: Resveratrol may have therapeutic value in the management of diseases involving pathological neovascularization.
Adult
;
Animals
;
Anoxia/metabolism/physiopathology
;
Cell Survival/drug effects
;
Choroidal Neovascularization/*metabolism/pathology
;
Humans
;
Hypoxia-Inducible Factor 1, alpha Subunit/*drug effects/metabolism
;
Mice
;
Mice, Inbred C57BL
;
Phosphatidylinositol 3-Kinases/antagonists & inhibitors/*physiology
;
Proteasome Endopeptidase Complex
;
Proto-Oncogene Proteins c-akt/antagonists & inhibitors/*physiology
;
Retinal Pigment Epithelium/*drug effects/metabolism
;
Signal Transduction
;
Stilbenes/administration & dosage/*pharmacology
;
TOR Serine-Threonine Kinases/antagonists & inhibitors/*physiology
;
Ubiquitin
;
Vascular Endothelial Growth Factor A/*drug effects/metabolism